CureVac to Report Third Quarter and First Nine Months 2023 Financial Results and Business Updates on November 14, 2023
CureVac N.V. , a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (“mRNA”), will report financial results, and provide business updates for the third quarter and first nine months of 2023 on Tuesday, November 14, 2023.
The company will host a conference call and webcast on the same day at 9 a.m. ET / 3 p.m. CET.